Amanta Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Pat Growth 25pctExceptional ItemEbitda Margin CompressionResults View source PDF

AMANTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-4.7%1-day move

₹132.00

prior close

₹131.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.1-1.9-1.5-2.3-4.7-1.5-0.8+1.3+0.2-8.3+12.6+21.6+24.7—

Up moveDown movePending

AI summary

Amanta Healthcare Limited reported revenue from operations of Rs 28,767.67 lakhs for FY26, up 4.7% from Rs 27,470.82 lakhs in FY25. Profit after tax grew 41.7% to Rs 1,487.52 lakhs from Rs 1,050.07 lakhs. The company completed its IPO in September 2025, raising Rs 12,600 lakhs, with Rs 5,246.75 lakhs still unutilized as of March 2026. An exceptional item of Rs 262.88 lakhs was recognized for IPO-related listing expenses. Finance costs decreased significantly to Rs 2,074.57 lakhs from Rs 2,794.79 lakhs due to early redemption of non-convertible debentures. Cash and cash equivalents improved substantially to Rs 8,101.03 lakhs from Rs 22.06 lakhs. Capital work-in-progress increased sharply to Rs 8,151.77 lakhs from Rs 654.80 lakhs due to expansion projects at the Hariyala facility.

Likely market impact

Strong PAT growth of 41.7% and successful IPO with doubled equity base are positives, but EBITDA margin compression to ~20.8% and heavy capital expenditure with substantial unutilized IPO proceeds warrant monitoring.